Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3245]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Better doctor-patient communication needed to improve myeloma outcomes
Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK
Better doctor-patient communication needed to improve myeloma outcomes ( Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK )
2 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016
Elderly patients should be treated based on biological age, not chronological
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
Elderly patients should be treated based on biological age, not chronological ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
2 Nov 2016
Cancer or amyloidosis?
Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center...
Cancer or amyloidosis? ( Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center, Pavia, Italy )
2 Nov 2016
Monoclonal antibodies in multiple myeloma
Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France
Monoclonal antibodies in multiple myeloma ( Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France )
1 Nov 2016
Preemptively treating patients most at risk of progression to myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Preemptively treating patients most at risk of progression to myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
1 Nov 2016
Drug combos with daratumumab likely to become standard of care in myeloma
Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland
Drug combos with daratumumab likely to become standard of care in myeloma ( Dr Niels Van De Donk - VU University Medical Center, Amsterdam, Holland )
1 Nov 2016
Overview of the CD38 antibody in multiple myeloma
Dr Torben Plesner - Vejle Hospital, Vejle, Denmark
Overview of the CD38 antibody in multiple myeloma ( Dr Torben Plesner - Vejle Hospital, Vejle, Denmark )
1 Nov 2016
New drugs and combinations in haematological cancers improve complete remission...
Dr Paolo Corradini - University of Milan, Milan, Italy
New drugs and combinations in haematological cancers improve complete remission rates ( Dr Paolo Corradini - University of Milan, Milan, Italy )
1 Nov 2016
Benefits and problems of allogeneic stem cell transplantation as multiple...
Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany
Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment ( Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany )
1 Nov 2016
Innovative uses of kinase inhibitors in cancer
Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
Paediatric ALL with brain metastases
Dr Christina Halsey - University of Glasgow, Glasgow, UK
Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )
5 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation